GlassScriptPhysician profile
Brian Da Costa Gill
NPI 1164528717
$8,570.35
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $2,206 · 2021: $6,099 · 2024: $81.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,052.91 | 2019-2021 | |
| Davol INC. | $132.93 | 2019-2020 | |
| Varian Medical Systems, INC. | $92.31 | 2020 | |
| Tela Bio, INC. | $81.32 | 2024 | Ovitex 2s |
| Takeda Pharmaceuticals U.S.A., INC. | $73.45 | 2020-2021 | |
| Acell, INC. | $36.49 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $26.39 | 2019 | |
| Integra Lifesciences Corporation | $23.69 | 2021 | |
| Merck Sharp & Dohme LLC | $19.06 | 2019 | |
| Innocoll Pharmaceuticals Limited | $16.04 | 2021 | |
| Boston Scientific Corporation | $15.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.